273543 Innovating to Save More Lives in International Maternal

Tuesday, October 30, 2012 : 9:00 AM - 9:15 AM

Harshadkumar Sanghvi, MD , Vice-President & Medical Director, Jhpiego, Johns Hopkins University, Baltimore, MD
To achieve urgently needed reductions in morbidity and mortality among women and families in developing nations, we require evidence based interventions to reach coverage, quality and impact at scale. Where health care systems are fragile, facility based services marginalize 50% of the population especially those most in need.

One strategy is to take care to families rather than wait for them in facilities. We describe innovative technology and process solutions that hold the promise for universal coverage. Tools such as low cost simulators for frontline health workers to rapidly acquire and maintain skills to save lives, Solutions to make it easier for providers to do the right thing such as interactive , talking job aids, and point of care diagnostics, and processes to enhance quality of care and clinical governance. We describe how technologies can be introduced and scaled to achieve transformational improvements in health care for the most marginalized.

Learning Objectives:
1. Describe 2 technology and 2 process based interventions with significant promise to impact maternal and newborn health 2. Discuss how new technologies can be effectively introduced and scaled in low resorce settings

Keywords: Maternal and Child Health, Reproductive Health

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been the principle or co principle of multiple grants to develop, introduce and scale up program and technology innovations in the area of family planning, Maternal and Newborn care, Cervica cancer, Quality improvement and training
Any relevant financial relationships? Yes

Name of Organization Clinical/Research Area Type of relationship
Laerdal Foundation and laerdal Global Health Maternal and newborn Health Jointly develop low cost technologies for health problems of most marginalised communities

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.